Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,421 | 528 | 96.8% |
| Education | $308.27 | 21 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,341 | 69 | $0 (2024) |
| Lilly USA, LLC | $691.38 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $680.58 | 35 | $0 (2024) |
| ABBVIE INC. | $669.03 | 52 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $599.69 | 34 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $513.01 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $498.35 | 26 | $0 (2024) |
| PFIZER INC. | $480.61 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $397.66 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $289.32 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,654 | 88 | Otsuka America Pharmaceutical, Inc. ($248.36) |
| 2023 | $2,150 | 106 | Novo Nordisk Inc ($243.11) |
| 2022 | $1,815 | 93 | Novo Nordisk Inc ($317.96) |
| 2021 | $1,294 | 78 | Novo Nordisk Inc ($257.56) |
| 2020 | $893.35 | 51 | AstraZeneca Pharmaceuticals LP ($213.11) |
| 2019 | $819.95 | 63 | Braintree Laboratories, Inc. ($180.00) |
| 2018 | $553.51 | 35 | SANOFI-AVENTIS U.S. LLC ($92.82) |
| 2017 | $549.04 | 35 | PFIZER INC. ($93.76) |
All Payment Transactions
549 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.58 | General |
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Oncology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: DERMATOLOGY | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Neurology | ||||||
| 08/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PAIN | ||||||
| 08/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 710 | 982 | $116,048 | $58,897 |
| 2022 | 12 | 623 | 1,011 | $138,327 | $68,394 |
| 2021 | 12 | 484 | 815 | $108,360 | $44,367 |
| 2020 | 15 | 639 | 1,142 | $225,654 | $65,428 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 133 | 243 | $23,059 | $13,554 | 58.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 79 | 138 | $17,250 | $11,029 | 63.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 154 | $27,566 | $10,188 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 79 | 79 | $14,457 | $10,070 | 69.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 62 | 62 | $7,316 | $3,351 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 58 | $7,366 | $3,115 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 23 | $5,750 | $2,726 | 47.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 50 | 75 | $4,500 | $2,292 | 50.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 38 | 52 | $6,968 | $1,224 | 17.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 41 | 41 | $1,066 | $748.25 | 70.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $540.00 | $401.88 | 74.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 45 | $210.37 | $197.49 | 93.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 125 | 275 | $26,125 | $14,372 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 173 | $30,967 | $13,996 | 45.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 83 | 160 | $20,000 | $11,469 | 57.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 54 | $13,500 | $6,519 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 110 | $13,970 | $6,038 | 43.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 31 | 31 | $5,487 | $3,172 | 57.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $4,026 | $2,901 | 72.1% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 21 | 21 | $4,767 | $2,754 | 57.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 32 | $8,210 | $2,579 | 31.4% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 50 | 69 | $4,140 | $2,233 | 53.9% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 17 | 17 | $2,091 | $1,140 | 54.5% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 25 | 36 | $4,824 | $1,007 | 20.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $220.00 | $215.60 | 98.0% |
About Dr. Paul Harvey, MD
Dr. Paul Harvey, MD is a Internal Medicine healthcare provider based in Riverdale, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053410357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Harvey, MD has received a total of $9,729 in payments from pharmaceutical and medical device companies, with $1,654 received in 2024. These payments were reported across 549 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($9,421).
As a Medicare-enrolled provider, Harvey has provided services to 2,456 Medicare beneficiaries, totaling 3,950 services with total Medicare billing of $237,085. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Riverdale, GA
- Active Since 09/22/2006
- Last Updated 03/12/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053410357
Products in Payments
- REXULTI (Drug) $557.77
- Kerendia (Drug) $498.35
- Saxenda (Drug) $477.44
- VRAYLAR (Drug) $417.98
- ELIQUIS (Drug) $359.10
- ENTRESTO (Drug) $314.81
- FARXIGA (Drug) $302.55
- MOUNJARO (Drug) $293.61
- SOLIQUA 100/33 (Biological) $272.70
- TRULICITY (Drug) $259.34
- HETLIOZ (Drug) $258.03
- Ozempic (Drug) $251.11
- UBRELVY (Drug) $246.47
- BREZTRI (Drug) $243.37
- XARELTO (Drug) $239.10
- GEMTESA (Drug) $210.37
- Rybelsus (Drug) $188.52
- SUPREP BOWEL PREP (Drug) $169.38
- JARDIANCE (Drug) $140.96
- SOLIQUA (Drug) $118.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Riverdale
Dr. Victor Okeh, M.d, M.D
Internal Medicine — Payments: $21,812
Sureshkumar Muttath, M.d, M.D
Internal Medicine — Payments: $15,838
Dr. Richard Wright, Md, MD
Internal Medicine — Payments: $9,967
Reva Gill, Md, MD
Internal Medicine — Payments: $5,883
Mr. Rao Mikkilineni, M.d, M.D
Internal Medicine — Payments: $5,799
Eduardo Flores, Md, MD
Internal Medicine — Payments: $5,613